Molecular modeling and functional analysis of exome sequencing-derived variants of unknown significance identify a novel, constitutively active FGFR2 mutant in cholangiocarcinoma

Jan B. Egan, David L. Marks, Tara L. Hogenson, Anne M. Vrabel, Ashley N. Sigafoos, Ezequiel J. Tolosa, Ryan M. Carr, Stephanie L. Safgren, Elisa Enriquez Hesles, Luciana L. Almada, Paola A. Romecin-Duran, Eriko Iguchi, Aryan Ala'Aldeen, Jean Pierre A. Kocher, Gavin R. Oliver, Naresh Prodduturi, David W. Mead, Asif Hossain, Norine E. Huneke, Colleen M. TagtowSikander Ailawadhi, Stephen M. Ansell, Michaela S. Banck, Alan H. Bryce, Estrella M. Carballido, Asher A. Chanan-Khan, Kelly K. Curtis, Ernesto Resnik, Chelsea D. Gawryletz, Ronald S. Go, Thorvardur R. Halfdanarson, Thai H. Ho, Richard W. Joseph, Prashant Kapoor, Aaron S. Mansfield, Nathalie Meurice, Amulya A.Nageswara Rao, Grzegorz S. Nowakowski, Animesh Pardanani, Sameer A. Parikh, John C. Cheville, Andrew L. Feldman, Ramesh K. Ramanathan, Steven I. Robinson, Raoul Tibes, Heidi D. Finnes, Jennifer B. McCormick, Robert R. McWilliams, Aminah Jatoi, Mrinal M. Patnaik, Alvin C. Silva, Eric D. Wieben, Tammy M. McAllister, Kandelaria M. Rumilla, Sarah E. Kerr, Konstantinos N. Lazaridis, Gianrico Farrugia, A. Keith Stewart, Karl J. Clark, Eileen J. Kennedy, Eric W. Klee, Mitesh J. Borad, Martin E. Fernandez-Zapico

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint Dive into the research topics of 'Molecular modeling and functional analysis of exome sequencing-derived variants of unknown significance identify a novel, constitutively active FGFR2 mutant in cholangiocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences